ENDRA Life Sciences Inc. (NDRA) Financials
NDRA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 7.6 million | 2.4 million |
2023-06-30 | 9.2 million | 2.3 million |
2023-03-31 | 6.7 million | 2.2 million |
2022-12-31 | 9.3 million | 2.1 million |
NDRA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -2.6 million | 252739 |
2023-06-30 | -2.3 million | 255855 |
2023-03-31 | -2.5 million | 237279 |
2022-12-31 | -3.1 million | 290769 |
NDRA Net Income
No data available :(
NDRA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 3.3 million | - | 405773 |
2023-06-30 | 4.8 million | - | 444167 |
2023-03-31 | 2.4 million | - | 481618 |
2022-12-31 | 4.9 million | - | 518147 |
NDRA Shares Outstanding
NDRA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 1.6 million | 1.3 million | 243332 |
2023-06-30 | - | 1.4 million | 1.3 million | 247773 |
2023-03-31 | 27000 | 1.4 million | 1.4 million | 181616 |
2022-12-31 | 38563 | 1.7 million | 1.3 million | 326769 |
NDRA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 70449 |
2023-06-30 | - | 72713 |
2023-03-31 | - | 71042 |
2022-12-31 | - | 67769 |
NDRA
Price: $0.33
52 week price:
Earnings Per Share: -2.56 USD
P/E Ratio: -0.46
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 4700
Ebitda: -2.3 millionMarket Capitalization: 3.9 million